About ISOVive
ISOVive is a company based in Manassas (United States) founded in 2013 by Peter Swann and Jack Oswald. It operates as a D2C. ISOVive has raised $8.14 million across 1 funding round. ISOVive offers products and services including ISOVive Prebiotic Nectar. ISOVive operates in a competitive market with competitors including Sova Health, Infinant Health, rmdy, Ateria Health and G-NiiB, among others.
- Headquarter Manassas, United States
- Founders Peter Swann, Jack Oswald
- SectorsHealthcare
- Email••••••••
- Website isovive.com
- Social X Facebook Instagram
- Total Equity Funding$8.14M (USD)
in 1 rounds
- Latest Funding Round$8.14M (USD), Series A
Oct 2025
Products & Services of ISOVive
ISOVive offers a comprehensive portfolio of products and services, including ISOVive Prebiotic Nectar.
Fermented prebiotic for balancing gut bacteria and relieving indigestion.
Funding Insights of ISOVive
ISOVive has successfully raised a total of $8.14M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.14 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.14M
- Total Rounds 1
- Last Round Series A — $8.14M
- First Round $8.14M
(Oct 2025)
All 1 funding rounds of ISOVive with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $8.14M | Series A | – | – | – |
People of ISOVive
2 people are tracked at ISOVive (2 in leadership).
| Name | Role | Group |
|---|---|---|
Peter Swann | Co-Founder | Leadership |
Jack Oswald | Co-Founder, CEO | Leadership |
Complete people profiles for ISOVive
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ISOVive
2 dated milestones of ISOVive across 12 years, from founding to its latest funding, stage changes and deals.
- Founded ISOVive is founded.
- Funding First funding round of $8.1M.
Competitors of ISOVive
ISOVive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sova Health, Infinant Health, rmdy, Ateria Health and G-NiiB, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sova.health | 2019 | Gurugram, India | $1.35M | 47 | Microbiome testing, consultations, and gut health supplements are offered. | |
| infinanthealth.com | 2011 | Norwalk, United States | – | – | Microbiome-based products to improve infant immune system | |
| rmdy.com | 2018 | Philadelphia, United States | – | 5 | Developer of chewable tablets for improving digestion | |
| ateriahealth.com | 2017 | Ledbury, United Kingdom | – | 3 | Food supplements for gut health are developed by Ateria Health. | |
| g-niib.com | 2020 | Hong Kong, China | – | – | Develops innovative microbiome-based technologies for disease diagnostics and treatments. | |
| advanced-biotics.com | 2021 | Plymouth, United Kingdom | – | – | Developer of probiotics for gut health | |
| atrantil.com | 2012 | Dallas, United States | $2.38M | – | Digestive health supplements are manufactured and marketed by Atrantil. |
Detailed competitors of ISOVive
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ISOVive
The website of ISOVive (isovive.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with ISOVive. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for ISOVive
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Isovive
Complete news archive for ISOVive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ISOVive
10 companies that operate in the same segment as ISOVive (Microbiome Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Biosolutions and enzymes are developed for biotechnology applications across industries. | 2000 | Bags Sword, Denmark | – | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Gut microbiome insights, analytics, tests, and therapeutics are provided. | 2019 | Singapore, Singapore | USD 10.5 M | USD 1.37 M | – | |
Microbiome-based therapeutics for skin conditions like eczema are developed. | 2014 | Farmington, United States | USD 37.4 M | – | 12 | |
Engineered microbes are developed as programmable therapeutics for metabolic disorders. | 2013 | Cambridge, Massachusetts, United States | USD 34.4 M | USD 8 K | 1 | |
Therapeutics for infectious and autoimmune diseases are developed. | 2010 | Cambridge, Massachusetts, United States | USD 470.49 M | – | 71 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Microbiome-based therapeutics for gut diseases are developed. | 2017 | Edinburgh, Scotland, United Kingdom | USD 72.96 M | – | 65 | |
The gut-brain axis is explored for therapeutic and nutritional innovations. | 2014 | New York, New York, United States | USD 479 M | – | 84 | |
Microbiome therapeutics are developed to address diverse diseases. | 2010 | Cambridge, Massachusetts, United States | USD 257.13 M | USD 789 K | 103 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ISOVive
ISOVive was founded in 2013 and raised its 1st funding round 12 years after it was founded.
ISOVive is headquartered in Manassas, United States. It is registered at Manassas, Virginia, United States.
Jack Oswald is the current CEO of ISOVive. They have also founded this company.
ISOVive is a funded company, having raised a total of $8.14M across 1 funding round to date. The company's 1st funding round was a Series A of $8.14M, raised on Oct 2025.
ISOVive is a naturally fermented prebiotic nectar supplement that supports digestive health by balancing gut bacteria and providing relief from heartburn and indigestion. It works by feeding beneficial microbes with its unique MIMO prebiotic, addressing microbiome imbalances caused by modern diets. Based in Manassas, VA, USA, the company offers online sales with a 30-day money-back guarantee and is backed by scientific research and medical experts.
ISOVive's top competitors include Sova Health, Infinant Health and rmdy.
ISOVive offers ISOVive Prebiotic Nectar.
The website of ISOVive receives about 681 thousand visits a month.